BioSyent Inc.

TSXV:RX Stock Report

Market Cap: CA$132.8m

BioSyent Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

TSXV:RX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
23 May 25SellCA$4,327Peter LockhardIndividual363CA$11.95
22 May 25SellCA$2,350Peter LockhardIndividual200CA$11.75
28 Mar 25SellCA$27,547Sharan RaghubirIndividual2,475CA$11.13
21 Mar 25SellCA$450Peter LockhardIndividual40CA$11.25
19 Mar 25SellCA$5,625Peter LockhardIndividual500CA$11.25
18 Mar 25SellCA$1,125Peter LockhardIndividual100CA$11.25
06 Jan 25SellCA$1,370,447FAX Capital Corp.Company122,910CA$11.15
23 Dec 24SellCA$1,267,557FAX Capital Corp.Company112,400CA$11.28
16 Dec 24SellCA$5,039Seyed AshrafiIndividual419CA$12.04
04 Dec 24SellCA$305,291FAX Capital Corp.Company27,500CA$11.10
25 Nov 24SellCA$7,294Peter LockhardIndividual637CA$11.45
22 Nov 24SellCA$2,619,768FAX Capital Corp.Company235,500CA$11.33
07 Nov 24SellCA$52,837FAX Capital Corp.Company4,700CA$11.24
30 Sep 24SellCA$23,455Sharan RaghubirIndividual2,213CA$10.81
23 Sep 24SellCA$7,050Peter LockhardIndividual635CA$11.15
23 Jul 24SellCA$5,025,000FAX Capital Corp.Company500,000CA$10.05
28 Jun 24SellCA$4,247Sharan RaghubirIndividual423CA$10.04
20 Jun 24SellCA$55,112Sharan RaghubirIndividual5,505CA$10.01
12 Jun 24SellCA$14,276René GoehrumIndividual1,522CA$9.38

Insider Trading Volume

Insider Buying: RX insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of RX?
Owner TypeNumber of SharesOwnership Percentage
Private Companies1,087,7619.67%
Individual Insiders1,591,02614.1%
Institutions2,163,63219.2%
General Public6,412,21957%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 20 shareholders own 43.03% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.67%
1069867 Ontario Ltd
1,087,761CA$12.8m0%no data
9.62%
FAX Capital Corp.
1,082,790CA$12.8m-10.2%100.0%
9.23%
René Goehrum
1,038,543CA$12.3m0%no data
4.44%
Intrepid Equity Finance Ltd., Investment Arm
500,000CA$5.9m0%no data
1.92%
Canadian Western Trust, Asset Management Arm
216,483CA$2.6m7.06%100.0%
1.78%
Van Berkom and Associates Inc.
200,172CA$2.4m0%0.05%
1.63%
Peter Lockhard
183,682CA$2.2m-0.31%no data
1.46%
Grandeur Peak Global Advisors, LLC
164,187CA$1.9m0%0.04%
0.59%
Kevin Wilson
66,747CA$787.6k-0.89%no data
0.55%
Robert March
61,585CA$726.7k4.03%no data
0.5%
Joost van der Mark
56,350CA$664.9k3.86%no data
0.42%
Seyed Ashrafi
47,745CA$563.4k2.93%no data
0.32%
Sharan Raghubir
36,043CA$425.3k3.36%no data
0.2%
Neelu Atwal
22,269CA$262.8k5.43%no data
0.17%
Ramesh Moothan
19,504CA$230.2k5.59%no data
0.14%
Sara Elford
15,411CA$181.8k0%no data
0.13%
Marnie Mccormick
14,815CA$174.8k58.7%no data
0.11%
Joseph Arcuri
12,854CA$151.7k0%no data
0.091%
Larry Andrews
10,253CA$121.0k0%no data
0.046%
Stephen Wilton
5,225CA$61.7k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/02 20:48
End of Day Share Price 2025/05/30 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BioSyent Inc. is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David MartinBloom Burton & Co.
Scott CurtisCantor Fitzgerald Canada Corporation
Tania Armstrong-WhitworthCormark Securities Inc.